Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Study identifies two factors that may help patients benefit from off-the-shelf CAR T-cell therapies

Researchers at The University of Texas MD Anderson Cancer Center have traced how off-the-shelf chimeric antigen receptor (CAR) T cells behave in patients, revealing how immune rejection and differences among CAR T cells influence their ability to multiply after infusion.

Study identifies two factors that may help patients benefit from off-the-shelf CAR T-cell therapies

We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.

Read the original at medicalxpress.com →

More in Health & Medicine

COVID-19, flu shots available to high risk, priority groups starting Sept. 28

COVID-19 and flu vaccines will be available for high risk and priority groups in Ontario starting Sept. 28, launching the province’s fall immunization program.

  • COVID-19, flu, and RSV vaccines available starting Sept. 28 in Ontario
  • High-risk groups prioritized: hospitalized patients, long-term care residents
  • Flu shots and RSV vaccinations accessible from Oct. 26 at various locations

More from Friday 25 September →